Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-07

Clinical Trial Update: Laboratory Screening of Lorcaserin for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial update on laboratory screening of lorcaserin for alcohol use disorder, terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorcaserin (lorcaserin)

Snippet

Sponsor: The Mind Research Network | Conditions: Alcohol Use Disorder, Tobacco Smoking | Phase 2 | Status: TERMINATED | Results posted: 2022-09-07